Drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for leukopenia and malignant tumors, which is applied in the field of medicines and preparations for the treatment of leukopenia caused by radiotherapy and chemotherapy of malignant tumors, and can solve the problems of slow curative effect and low bioavailability
Active Publication Date: 2010-08-18
TSING HUA DE REN XIAN HAPPINESS PHARMA
View PDF0 Cites 9 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, the traditional treatment of leukopenia caused by radiotherapy and chemotherapy fo
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
specific Embodiment 1
[0136] The medicine preparation method of the present invention is made up of following composition:
[0153] Paeoniae Alba 350g Astragalus 350g Dog spine 350g;
[0154] The preparation method is the same as in specific example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor and a preparation method thereof. The traditional drug for treating leukopenia caused by concurrent chemoradiotherapy of malignant tumor has incomplete absorption, low bioavailability and slow curative effect. The drug comprises seven types of traditional Chinese medicines, such as radix polygonum multiflorum preparata, glossy privet fruit, mulberry, yerbadetajo herb, white paeony root, raidx astragali and rhizoma cibotii. In the invention, the yerbadetajo herb is monarch drug, the glossy privet fruit and the mulberry have the effect of strengthening the nourishing of the liver and kidney of the monarch drug, and are ministerial drugs in the formula, and the raidx astragali is adjuvant drug and is matched with the monarch drug and the ministerial drugs to enhance the treating effect; the radix polygonum multiflorum preparata, the white paeony root and the rhizoma cibotii are used for assisting the monarch drug and the ministerial drugs to strengthen the treatment of syndrome of the deficiency of yin and blood. The whole formula has the effects of nourishing the liver and the kidney and benefiting vital energy and blood, are used for treating the symptoms such as leukopenia, mental fatigue and acratia, fatigue and weakness of waist and knee, dizziness and tinnitus, palpitation, shortness of breath, agrypnia, dryness of the throat, bad food intake and little eating and the like.
Description
Technical field: [0001] The invention relates to a medicine for treating leukopenia caused by radiotherapy and chemotherapy of malignant tumors and a preparation method thereof. The medicine has the effects of nourishing the liver and kidney and replenishing qi and blood, and is used for leukopenia and fatigue caused by radiotherapy and chemotherapy of malignant tumors. , Weak waist and knees, dizziness, tinnitus, palpitations, shortness of breath, insomnia, dry throat, anorexia and lack of food embolism. technical background: [0002] It is a classic Chinese patent medicine for the treatment of leukopenia caused by radiotherapy and chemotherapy of malignant tumors. It is used for leukopenia, mental fatigue, weak waist and knees, dizziness, tinnitus, palpitations, shortness of breath, insomnia, dry throat, poor appetite and other diseases caused by chemotherapy and radiotherapy of malignant tumors. However, the traditional treatment of leukopenia caused by radiotherapy and ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more